← SynDRA
AZD-1080
SynDRA canonical compound SYN0028827 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GSK3A | GSK3B |
|---|
| Mechanism of action | glycogen synthase kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- GSK3A INHIBITOR
- Glycogen synthase kinase-3 inhibitor
- GSK3B INHIBITOR
- glycogen synthase kinase inhibitor
Cross-references
Synonyms
- AZ-11548415
- AZD1080
- 0TII45R8IJ
- CHEBI:167651
- RefChem:115984
- UNII-0TII45R8IJ
- MFCD12031593
- Kinome_2945
- SCHEMBL394519
- GTPL7819
- orb1307560
- SCHEMBL18642421
- SCHEMBL18642422
- SCHEMBL22604618
- SCHEMBL29361806
- SCHEMBL29374248
- SCHEMBL30298327
- SCHEMBL31032587
- EX-A230
- BLTVBQXJFVRPFK-UHFFFAOYSA-N
- GLXC-90136
- HMS3653I11
- HMS3886F11
- AZD1080?
- MZA48772
- BDBM50267626
- s7145
- AKOS026674123
- AKOS026750189
- AKOS032947292
- CCG-267852
- CS-1520
- NCGC00386283-04
- NCGC00386283-07
- NCGC00389257-01
- AC-32728
- AS-55896
- HY-13862
- DB-293119
Look up AZD-1080 in the interactive SynDRA portal →